Real-world long-term benefits of disease-modifying MS therapy
نویسندگان
چکیده
منابع مشابه
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients.
Two methods were used to estimate the long-term impact of disease-modifying drug therapy (DMDT) in patients with relapsing multiple sclerosis (MS) who completed a placebo-controlled, randomized clinical trial of interferon beta-1a (IFNbeta-1a). The study cohort consisted of patients with ambulatory relapsing MS who had previously participated in a placebo-controlled clinical trial for two years...
متن کاملLong-term benefits from investing in international real estate
This paper analyses longand short-term co-movements between 14 international real estate stock markets based on bivariate testing for cointegration and correlation analysis. The results indicate that there exist strong long-term relationships within economic and geographical regions, but less long-run linkages between real estate markets in different continents. Thus, investors would benefit fr...
متن کاملLong -Term Outcome Therapy of Toxic Diffuse Goiter in Tehran
SUMMARY In order to evaluate the long-ter m effects of antithyroids and ahlative therapy on patients with toxic diffuse goiter (TDG) in an iodine deficient region, 206 patients were studied in Tehran. Hyperthyroidism recurred in 50%, of 80 patients treated with Methimazole (MMI), from one week to 48 months after cessation of therapy. Another 40 patients remained in remission. Of 102 patients t...
متن کاملReal-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project.
There are few published data from real-world clinical experience with miglustat (Zavesca), an oral inhibitor of glucosylceramide synthase, in type 1 Gaucher disease. We report data from a prospective, open-label investigational study that evaluated substrate reduction therapy with miglustat 100 mg t.i.d. as a maintenance therapy in patients with Type 1 Gaucher disease who had been switched from...
متن کاملLong-term benefits of galantamine (Reminyl) in Alzheimer’s disease
The natural history of Alzheimer’s disease, combined with recognition of the advantages of introducing specific treatment early in the course of the disease, means that patients may take medication for several years. Previous studies of galantamine (Reminyl) have shown an excellent record of safety and efficacy over 12 months with a broad spectrum of benefits that includes functional and behavi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Neurology
سال: 2016
ISSN: 1759-4758,1759-4766
DOI: 10.1038/nrneurol.2016.76